גאלבוס 50 מ"ג

Страна: Ізраїль

мова: іврит

Джерело: Ministry of Health

Активний інгредієнт:

VILDAGLIPTIN 50 MG

Доступна з:

NOVARTIS PHARMA SERVICES AG

Код атс:

A10BH02

Фармацевтична форма:

TABLETS

Адміністрація маршрут:

PER OS

Виробник:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Терапевтична група:

VILDAGLIPTIN

Терапевтичні свідчення:

Galvus is indicated as an adjunct to diet and exercise in patients with type 2 diabetes mellitus• As monotherapy, if diet and exercise are not sufficient, or• In combination with metformin, or a sulfonylurea if treatment with these oral antidiabetics does not offer sufficient control of blood glucose.As triple oral therapy in combination with• a sulphonylurea and metformin when diet and exercise plus dual therapy with these agents do not provide adequate glycaemic control. Galvus is also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycaemic control.

Дата Авторизація:

2013-11-01